European Medicines Agency (EMA)

EMA publishes tool to track its progress to Amsterdam

The European Medicines Agency has produced a ‘tracker tool’ to follow progress of its move from London to Amsterdam.…

PM says UK should try to remain a member of the EMA after Brexit

In a speech billed as her vision for the future economic partnership between the UK and the EU, Theresa May spoke of her commitment to seeking for the UK to remain part of “critical” EU agencies.…

EMA revises guidance for medicines development in Alzheimer’s disease

European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a revised guideline on clinical studies for medicines that target Alzheimer’s disease.…

EMA outlines steps towards ethical use of medicines in animal testing

The European Medicines Agency has published its first report on how it is encouraging drug companies to use alternatives to animal testing in all stages of product development and manufacture.…

Government to review failures in responding to patient concerns over valproate

Health and social care secretary Jeremy Hunt has announced a review into the way the NHS and medicines regulators respond to reports from patients about side effects…

EMA recommends five new medicines for approval

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended five medicines for approval at its most recent meeting held 19–22 February 2018.…

EMA sets out new measures to avoid risk from valproate in pregnancy

All women of childbearing age prescribed the drug valproate — which has been linked to foetal abnormalities — will have to take part in a pregnancy prevention programme…

EMA launches two initiatives to improve medicine provision

EMA will hold a workshop with the European Commission on paediatric medicine to find out how better to apply paediatric legislation to boost development of medicines for children…

Sales of unapproved antibiotic formulations are rising in India, study finds

Sales of antibiotic fixed-dose combinations, including unapproved formulations, are rising in India, according to a study published in the British Journal of Clinical Pharmacology.…

European Medicines Agency surveys pharmaceutical companies on preparedness for Brexit

The EMA wants to identify issues that could disrupt medicines supply and impact on human and animal health when the UK exits the EU…